Kathleen R. Lamborn

31.7k total citations · 2 hit papers
292 papers, 22.7k citations indexed

About

Kathleen R. Lamborn is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kathleen R. Lamborn has authored 292 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Genetics, 89 papers in Radiology, Nuclear Medicine and Imaging and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kathleen R. Lamborn's work include Glioma Diagnosis and Treatment (159 papers), Brain Metastases and Treatment (43 papers) and Radiopharmaceutical Chemistry and Applications (37 papers). Kathleen R. Lamborn is often cited by papers focused on Glioma Diagnosis and Treatment (159 papers), Brain Metastases and Treatment (43 papers) and Radiopharmaceutical Chemistry and Applications (37 papers). Kathleen R. Lamborn collaborates with scholars based in United States, Canada and Germany. Kathleen R. Lamborn's co-authors include Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Patrick Y. Wen, Michael W. McDermott, Timothy F. Cloughesy, G. Evren Keles, William M. Wara, David A. Larson and Edward F. Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Kathleen R. Lamborn

288 papers receiving 22.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

2010 2.7k citations Patrick Y. Wen, Timothy F. Cloughesy et al. Journal of Clinical Oncology profile →
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

2008 904 citations Justin S. Smith, Kathleen R. Lamborn et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen R. Lamborn United States	81	12.8k	5.7k	5.6k	5.1k	4.1k	292	22.7k
R.O. Mirimanoff Switzerland	30	16.4k 1.3×	4.1k 0.7×	6.9k 1.2×	8.3k 1.6×	4.3k 1.0×	71	26.4k
Allan H. Friedman United States	75	12.2k 1.0×	3.6k 0.6×	4.8k 0.9×	7.2k 1.4×	3.4k 0.8×	345	25.7k
Michael D. Prados United States	90	18.8k 1.5×	4.4k 0.8×	7.4k 1.3×	7.9k 1.6×	4.0k 1.0×	418	27.6k
Mark R. Gilbert United States	77	15.1k 1.2×	3.9k 0.7×	6.8k 1.2×	6.6k 1.3×	3.0k 0.7×	491	24.8k
Jay S. Loeffler United States	86	11.3k 0.9×	4.0k 0.7×	11.8k 2.1×	4.6k 0.9×	5.9k 1.4×	368	27.0k
Riccardo Soffietti Italy	55	12.1k 0.9×	3.3k 0.6×	7.6k 1.4×	3.2k 0.6×	4.4k 1.1×	254	19.3k
Christine Marosi Austria	46	14.7k 1.1×	3.5k 0.6×	5.6k 1.0×	7.2k 1.4×	3.4k 0.8×	196	24.4k
Raymond Sawaya United States	84	11.6k 0.9×	3.7k 0.6×	7.2k 1.3×	8.4k 1.7×	6.2k 1.5×	351	28.2k
Haley Gittleman United States	33	11.7k 0.9×	2.9k 0.5×	4.3k 0.8×	6.2k 1.2×	4.4k 1.1×	77	21.1k
Barbara Fisher Canada	18	12.0k 0.9×	2.8k 0.5×	4.8k 0.9×	5.5k 1.1×	2.5k 0.6×	47	18.3k

Countries citing papers authored by Kathleen R. Lamborn

Since Specialization

Citations

This map shows the geographic impact of Kathleen R. Lamborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen R. Lamborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen R. Lamborn more than expected).

Fields of papers citing papers by Kathleen R. Lamborn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen R. Lamborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen R. Lamborn. The network helps show where Kathleen R. Lamborn may publish in the future.

Co-authorship network of co-authors of Kathleen R. Lamborn

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen R. Lamborn. A scholar is included among the top collaborators of Kathleen R. Lamborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen R. Lamborn. Kathleen R. Lamborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groot, John de, Kathleen R. Lamborn, Susan M. Chang, et al.. (2011). Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study. Journal of Clinical Oncology. 29(19). 2689–2695. 168 indexed citations

Iwamoto, Fábio M., Kathleen R. Lamborn, John G. Kuhn, et al.. (2011). A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro-Oncology. 13(5). 509–516. 94 indexed citations

Barbaro, Nicholas M., Mark Quigg, Donna K. Broshek, et al.. (2009). A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: Seizure response, adverse events, and verbal memory. Annals of Neurology. 65(2). 167–175. 124 indexed citations

McBride, Sean M., Daniel Pérez, Mei‐Yin C. Polley, et al.. (2009). Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. Journal of Neuro-Oncology. 97(1). 33–40. 59 indexed citations

Cage, Tene A., et al.. (2009). Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. Journal of Neuro-Oncology. 93(1). 151–156. 41 indexed citations

Papavassiliou, Efstathios, Geoff Rau, Susan Heath, et al.. (2008). THALAMIC DEEP BRAIN STIMULATION FOR ESSENTIAL TREMOR. Neurosurgery. 62(Supplement 2). 19 indexed citations

Schillaci, Orazio, Gerald L. DeNardo, Sally J. DeNardo, et al.. (2007). Effect of Antilymphoma Antibody, ¹³¹ I-Lym-1, on Peripheral Blood Lymphocytes in Patients with Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 22(4). 521–530. 1 indexed citations

Butowski, Nicholas, Kathleen R. Lamborn, Susan Chang, et al.. (2007). Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. Molecular Cancer Therapeutics. 6. 1 indexed citations

Wiencke, John K., Shichun Zheng, Tarık Tihan, et al.. (2007). Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-Oncology. 9(3). 271–279. 123 indexed citations

10.

Lassman, Andrew B., Michael R. Rossi, Lauren E. Abrey, et al.. (2005). Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clinical Cancer Research. 11(21). 7841–7850. 201 indexed citations

11.

Lü, Ying, Hua Jin, & Kathleen R. Lamborn. (2005). A design of phase II cancer trials using total and complete response endpoints. Statistics in Medicine. 24(20). 3155–3170. 23 indexed citations

12.

Chang, Susan M., Kathleen R. Lamborn, Mary Malec, et al.. (2004). Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 60(2). 353–357. 117 indexed citations

13.

Papavassiliou, Efstathios, Geoff Rau, Susan Heath, et al.. (2004). Thalamic Deep Brain Stimulation for Essential Tremor: Relation of Lead Location to Outcome. Neurosurgery. 54(5). 1120–1130. 173 indexed citations

14.

Keles, G. Evren, Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados, & Mitchel S. Berger. (2004). Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. Journal of neurosurgery. 100(1). 41–46. 89 indexed citations

15.

Prados, Michael D., Michael S. B. Edwards, Susan M. Chang, et al.. (1999). Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a phase II study. International Journal of Radiation Oncology*Biology*Physics. 43(2). 279–285. 52 indexed citations

16.

Prados, Michael D., et al.. (1997). Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. Journal of Neuro-Oncology. 32(3). 235–241. 141 indexed citations

17.

Barker, Fred G., Michael D. Prados, Susan M. Chang, et al.. (1996). Bromodeoxyuridine labeling index in glioblastoma multiforme: Relation to radiation response, age, and survival. International Journal of Radiation Oncology*Biology*Physics. 34(4). 803–808. 20 indexed citations

18.

Prados, Michael D., William M. Wara, Michael S. B. Edwards, et al.. (1996). Treatment of High-Risk Medulloblastoma and Other Primitive Neuroectodermal Tumors with Reduced Dose Craniospinal Radiation Therapy and Multi-Agent Nitrosourea-Based Chemotherapy. Pediatric Neurosurgery. 25(4). 174–181. 23 indexed citations

19.

Prados, Michael D., Kathleen R. Lamborn, Janet Wynne, et al.. (1994). Proliferative potential and prognostic evaluation of low-grade astrocytomas. Journal of Neuro-Oncology. 19(1). 1–9. 38 indexed citations

20.

DeNardo, Sally J., L.F. O'Grady, Daniel J. Macey, et al.. (1991). Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. PubMed. 18(6). 621–631. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact